Esterolytic activity of imidazole-containing polymers. Synthesis and characterization of copoly[1-alkyl-4- or 5-vinylimidazole/4(5)-vinylimidazole] and its catalytic activity in the hydrolysis of p-nitrophenyl acetate

The water-soluble monomers, 1-methyl-4-vinylimidazole, 1-methyl-5-vinylimidazole, 1-ethyl-5-vinylimidazole, and 1-propyl-5-vinylimidazole have been synthesized, polymerized, and copolymerized with 4(5)-vinylimidazole. The copolymers were characterized by ¹⁴C-labeling, NMR, pK_a determination and viscosity measurements. The monomer reactivity ratios determined by ¹⁴C counting are r₁ = 1.04; r₂ = 0.94 [M₁ = 4(5)-vinylimidazole, M₂ = 1-methyl-4-vinylimidazole] and r₁ = 1.01; r₂ = 0.86 [M₁ = 4(5)-vinylimidazole, M₂ = 1-methyl-5-vinylimidazole]. The esterolytic activity of the copolymers for the hydrolysis of p-nitrophenyl acetate (PNPA) at pH 7–8 in 28.5% ethanol–water was higher than that of the mixtures of homopolymers. At pH 5–6 the esterolytic activities of the copolymers and the mixtures were similar. The most efficient esterolytic activity for PNPA hydrolysis at pH 7.11 in 28.5% ethanol–water occurred for copolymers containing 75 mole % 4(5)-vinylimidazole and for copolymers containing 1-methyl-4-vinylimidazole rather than 1-methyl-5-vinylimidazole.     

Synthesis of 1-phenyl-3-methyl-4-alkyl-4-[N-methylbutyro(capro)lactyl]-5-pyrazolones

The corresponding hydrazones, which on heating are cyclized to give 1-phenyl-3-methyl-4-alkyl-(benzyl)-4-(2-oxopyrrolidinomethyl)- and 1-phenyl-3-methyl-4-alkyl(benzyl)-4-(N-methylcaprolactyl)pyrazolones, are formed in the reaction of alkyl(benzyl) (2-oxopyrrolidinomethyl)- and alkyl-(benzyl) (N-methylcaprolactyl)acetoacetic esters with phenylhydrazine.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 11, pp. 1546–1548, November, 1976.     

Synthesis and anti-TMV activity of novel N-(3-alkyl-1H-pyrazol-4-yl)-3-alkyl-4-substituted-1H-pyrazole-5-carboxamides

In order to investigate the biological activity of novel bis-pyrazole compounds,a series of N-（3-alkyl-5-（N-methylcarbamyl）- 1H-pyrazol-4-yl）-3-alkyl-4-substituted-1H-pyrazole-5-carboxamides were designed and synthesized with ethyl 3-alkyl-1H-pyrazole -5-carboxylate 1 as starting materials.N-Methyl-3-alkyl-4-amino-1H-pyrazole-5-carboxamides 6 were obtained from 1 via 5 steps.3-Alkyl-4-substitued-1H-pyrazole-5-carboxyl chlorides 4a,4b,11a,11b,11c or 12 were also obtained from 1 via several steps.Target compounds 7a-7g were obtained after the reaction of 6 with the above 1H-pyrazole-5-carboxyl chlorides.Preliminary bioassay showed some compounds possessing good inactivation effect against TMV（tobacco mosaic virus）.Compound 7a showed higher activity superior to ningnanmycin at a concentration of 5.0×10^-4 g/mL and equal activity at 1.0×10^-4 g/mL;7b and 7c showed equal activity to virazole both at concentrations of 5.0×10^-4 g/mL and 1.0×10^-4 g/mL.     

S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲的合成及生物活性

以2-巯基苯并噻唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并噻唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,1H NMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,化合物8a,8b,8c,8e,8f,8i,8j和8k的iNOS抑制活性强于阳性对照药氨基胍,其中化合物8j的iNOS抑制活性比氨基胍强26倍多.     

二甲基·[4-硝基-2-(氮杂苯并-15-冠-5)-1-酚氧基]合镓(Ⅲ)配合物的晶体结构

目前Ⅲ族金属有机化合物在半导体材料、特种陶瓷和电致发光材料等领域内有着广泛的应用［１］。对含酚结构的氮杂冠醚衍生物与三甲基镓反应生成的配合物,我们一直有着浓厚的兴趣,这对寻找新ＭＯ源和ＭＯＣＶＤ技术的发展有着重要作用。田敬智等合成了八个这样的新型配合物［２］,并用元素分析、红外、质谱和核磁进行了结构表征。在此基础上,我们培养出配合物二甲基·［４－硝基－２－（氮杂苯并－１５－冠－５）－ｌ－酚氧基］合镓（Ⅲ）的单晶,本文将对其结构进行深入 的研究。１实验１．ｌ配合物的合成 配合物参照文献［２］在氮气氛…     

二甲基·[4-硝基-2-(氮杂苯并-15-冠-5)-1-酚氧基]合镓(Ⅲ)配合物的晶体结构

The complex dimethylgallium- [4-nitro-2-(N-benzo-15-crown-5)-1-phenoxide ](C₂₃H₃₁N₂O₇Ga) has been synthesized by the method reported.The crystal X-ray diffraction analysis shows that the crystal belongs to the triclinic with space group P1, M = 517.23 and the unit cell parameters: a = 1.4501 (2), b = 1.5090(2), c = 1.3865 (6)nm, a = 105.58(1 ), β = 117.26(2), γ = 66.812(8)°, V= 2.464546nm³, Z =4, Dc = 1.39g·cm^-3, u = 11.6cm^-1, F(000) = 1080, R = 0.051, Rw = 0.064.The coordination number of Ga is four and the gallium atom is located in a distorted tetrahedron structure.     

Asymmetric Synthesis of （-）-（4R, 5R）-4-[5-（Benzo[1, 3]dioxol-5-yl）-4- hydroxyl- 1-（pyridin-2-yl）-4, 5-dihydro- 1H-pyrazol-3-yl]benzamide

For discovering novel small molecule inhibitors of transforming growth factor-β1(TGF-β1)type-I receptor(ALK5),we designed1,3,5-triaryl-4-hydroxyl-4,5-dihydro-1H-pyrazole(1)as target compound,mimic the structure of SB-431542which is a2-pyridyl substituted triarylimiazole inhibitor of ALK51.Racemic compound1showed moderate ALK5inhibitory activity in luciferase reporter assays[inhibition(%control):0.1umol/L8.79%;1umol/L19.05%].To investigate the influence of the absolute configuration of…     

Investigating spectrum of biological activity of 4- and 5-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides

In this study, a series of twenty-two 5-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides and ten 4-chloro-2-hydroxy-N-[2-(arylamino)-1-alkyl-2-oxoethyl]benzamides is described. The compounds were analyzed using RP-HPLC to determine lipophilicity. Primary in vitro screening of the synthesized compounds was performed against mycobacterial, bacterial and fungal strains. They were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. The compounds showed biological activity comparable with or higher than the standards isoniazid, fluconazole, penicillin G or ciprofloxacin. For all the compounds, the relationships between the lipophilicity and the chemical structure of the studied compounds as well as their structure-activity relationships are discussed.     

The esterolytic activity of poly(1-methyl-4- and -5-vinylimidazole) in water.

The water solubility of poly(1-Me-5-VIm) has made it possible to achieve phenomenal rate enhancements and to gain even greater insight into the mechanism of catalysis by polymeric imidazoles. The poly(1-Me-5-VIm)-catalyzed hydrolysis of S12- exhibited saturation in excess catalyst nad in excess substrate. Inhibition of the poly(1-Me-5-Vim) catalyzed hydrolysis of Sn- type substrates by analog inhibitors was also observed. The saturation apparently did not follow a simple Michaelis-Menten mechanism; however, the results could be rationalized by analogy to certain enzymatic systems. Multisite enzymes have long been known to display kinetic patterns different from that exhibited by enzymes with only one active site, i.e. such phenomena as sigmoidal rate vs [S] plots. These phenomena may arise entirely as a result of the multisite nature of the enzyme. Consequently, a synthetic macromolecular catalyst with multiple sites might also be expected to display such characteristics. The poly(1-Me-5-VIm)-catalyzed hydrolysis of S12- is apparently the first synthetic system in which such phenomena have been observed. The intermediacy of an apolar polymer substrate complex for the poly(1-Me-5-VIm)-catalyzed hydrolysis of S12- in water was given support by studies of the effect of temperature on the rate of hydrolysis. Activation parameters were determined for catalysis by 1,5-DMIm and by poly(1-Me-5-VIm). These results showed that the rate enhancement exhibited by the polymer was due entirely to a favorable entropy term.     

Polyfunctional pyrazoles. 4. Synthesis of 3-[3-aryl-1-(2-ethoxycarbonyl)-4-pyrazolyl]acrylic and-propionic acids

3-(3-Aryl-4-formyl-1-pyrazolyl)propionic acids are converted by Knoevenagel condensation under conditions of microwave activation into 3-[3-aryl-1-(2-ethoxycarbonyl)-4-pyrazolyl]acrylic acids. Reduction of the latter with hydrazine hydrate in the presence of Raney nickel gives 3-[3-aryl-1-(2-ethoxycarbonyl)-4-pyrazolyl]propionic acids. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 5, pp. 686–690, May, 2006.     

Regioselective synthesis of 1-(2,6-dichloro-4-trifluoromethylphenyl)- 4-alkyl-1H-[1,2,3]-triazoles

A new and efficient method for the synthesis of 1-(2,6-dichloro-4-trifluoromethylphenyl)-4-alkyl-1H-[1,2,3]-triazoles by the room temperature 1,3-dipolar cycloaddition of (2-azido-1,3-dichloro-5-trifluoromethyl)benzene with terminal alkynes in the presence of Cu (I) salt as catalyst is reported. All the reactions gave 1,4-disubstituted products with high regioselectivity, as no 1,5-disubstituted product was formed. The structures of all the title compounds have been confirmed by elemental analysis, 1H- and 13C-NMR and in addition, the structure of compound 5a was investigated by X-ray crystallography.     

Syntheses of 4-(benzo[b]furan-2 or 3-yl)- and 4-(benzo[b]-thiophen-3-yl)piperidines with 5-HT2 antagonist activity

The syntheses of 4-(benzo[b]furan-3-yl)piperidines, 4-(benzo[b]furan-2-yl)piperidines and 4-(benzo[b]thiophen-3-yl)piperidines with 5-HT₂ antagonist activity are described. Reaction of 1-acetyl-4-(2,4-difluorobenzo-yl)piperidine 2 with methyl glycolate gave methyl 6-fluoro-3-(1-acetylpiperidin-4-yl)benzo[b]furan-2-carboxylate 3 , which was converted to 2-[2-[4-(benzo[b]furan-3-yi)piperidin-1-yl]ethyl-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3-a]pyridin-3(2H)-one hydrochloride 9 . Analogous benzo[b]furans 17a-d and benzo[b]thiophenes 10a,b and 18a were prepared by a similar method. Cyclization of 4-fluoro-2-(4-pyridinylmethoxy)acetophenones 20a,b afforded 4-(benzo[b]furan-2-yl)pyridines 21a,b , which were converted to 2-[2-[4-(benzo[b]furan-2-yl)-piperidin-1-yl]ethyl-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochlorides 24a,b. Among them, benzo[b]furans 9 and 17a,d and benzo[b]thiophenes 10 and 18a showed potent 5-HT₂ antagonist activity in vitro.